Novo Nordisk A/S (NVO)

39.07 +0.57 (+1.48%) USD  |  NYSE  |  Mar 05, 16:00
39.21 +0.14 (+0.36%) Pre-Market: 05:29
More

Novo Nordisk Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --
DBV Technologies SA --